The global Charcot-Marie-Tooth disease treatment market is anticipated to undergo significant expansion in the coming years, driven by factors such as an rising prevalence of the illness, advancements in therapy, and booming healthcare spending. The market is divided by type of therapy, indication, pharmacy network, and region. Key companies in the